Description

Ergotaman-3',6',18-Trione, 2-Bromo-12'-Hydroxy-2'-(1-Methylethyl)-5'-(2-Methylpropyl)-, (2'β,5'α,8α)- (9Ci) is a complex, high-purity ergot alkaloid derivative, identified by CAS number 82796-58-5. This compound is of significant interest for advanced pharmaceutical research and development, particularly in the study of neurological pathways and receptor interactions. It serves as a critical intermediate or reference standard for researchers and manufacturers in the life sciences sector requiring structurally specific bioactive molecules.

Application

• Pharmaceutical Research Intermediate: Serves as a key synthetic building block or precursor in the development of novel therapeutic agents targeting central nervous system disorders.
• Reference Standard for Analytical Testing: Used in quality control laboratories for method development, validation, and the identification of related substances in complex matrices.
• Biochemical Research: Employed in in-vitro studies to investigate its biological activity, receptor binding affinity, and mechanism of action within neurological systems.
• Academic and Institutional Research: Provides a specialized chemical tool for universities and research institutes exploring the chemistry and pharmacology of ergot alkaloids.
• Process Development and Scale-up: Acts as a critical material for optimizing synthetic routes and scaling production of related active pharmaceutical ingredients (APIs).

Basic Information

Product Name	Ergotaman-3',6',18-Trione, 2-Bromo-12'-Hydroxy-2'-(1-Methylethyl)-5'-(2-Methylpropyl)-, (2'β,5'α,8α)- (9Ci)
CAS No.	82796-58-5
Molecular Formula	C32H38BrN3O5
Molecular Weight	624.57 g/mol
Synonyms	2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione; 2-Bromo-12'-hydroxy-2'-isopropyl-5'-isobutylergotaman-3',6',18-trione; (2'beta,5'alpha,8alpha)-2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione; Brominated Ergotaman Derivative; Ergot Alkaloid Bromo Derivative; 82796-58-5; 2-Bromo-12'-hydroxy-2'-isopropyl-5'-isobutyl-ergotaman-3',6',18-trione
EINECS	Contact for details

Quality Control

Every batch of our high-purity ergot alkaloid derivatives is produced and tested under a strict quality management system. We employ advanced analytical techniques including HPLC, NMR, and MS to ensure identity, purity, and consistency. A comprehensive Certificate of Analysis (COA) detailing all specifications and test results is provided with each shipment to support your regulatory and research requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). This compound may be light-sensitive and/or hygroscopic; handle and store under an inert atmosphere if specified for your grade.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC)	Conforms to reference standard
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 95.0% (Area %)
Related Substances (HPLC)	Total impurities ≤ 5.0%
Loss on Drying	≤ 2.0 %
Residue on Ignition	≤ 0.5 %

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.